December 15, 2024 17:50 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Kolkata woman strangled, beheaded and chopped into pieces for refusing brother-in-law's advances | Arvind Kejriwal, CM Atishi to contest Delhi polls from current constituencies | Atul Subhash suicide case: Wife Nikita, her mother and brother arrested | Pushpa 2 stampede: Allu Arjun walks out of jail, actor's lawyer slams delay in release | Donald Trump intends to end 'inconvenient' and 'very costly' Daylight Saving Time | Suchir Balaji: Indian-origin former OpenAI researcher found dead at US apartment | Bengaluru techie suicide: Karnataka Police issues summons to wife Nikita, her family members | French President Macron appoints centrist leader Francois Bayrou as new Prime Minister | Congress always prioritised personal interest over Constitution: Rajnath Singh | Jaishankar calls attack on Hindus in Bangladesh 'a source of concern'
Octogenarian Covid19 patient given monoclonal antibody cocktail discharged from Gurgaon hospital

Octogenarian Covid19 patient given monoclonal antibody cocktail discharged from Gurgaon hospital

May 27, 2021, at 06:04 am

Gurugram/IBNS: An 84-year-old Covid-19 patient who was treated with a monoclonal antibodies cocktail was released from a hospital here after receiving the jab the day before, said media reports.

Covid antibody cocktail, used for treating Donald Trump, launched in India

Covid antibody cocktail, used for treating Donald Trump, launched in India

May 25, 2021, at 05:29 am

New Delhi/IBNS: Pharmaceutical major Roche India on Monday announced that it has launched the first batch of antibody cocktail against COVID-19 in the Asian country.

Covid-19: Roche India gets emergency use approval for its antibody cocktail that prevents severe infection

Covid-19: Roche India gets emergency use approval for its antibody cocktail that prevents severe infection

May 06, 2021, at 03:47 am

New Delhi/IBNS: Pharma major Roche India on Wednesday announced that it has received Emergency Use Approval (EUA) from Central Drugs Standards Control Organisation (CDSCO) for its antibody cocktail for treating Covid-19, said media reports.